Qingdao Care Biopharmaceutical Limited, as a wholly-owned subsidiary of Beijing Ruiboen Technology Group，we are a dedicated Contract Research and Manufacturing Organization (CRO/CDMO) providing integrated, end-to-end services for the development and production of small molecule Active Pharmaceutical Ingredients (APIs). Our partner with pharmaceutical and biotech companies worldwide to transform innovative scientific concepts into high-quality, commercially viable therapies, efficiently and reliably.

We are committed to providing high-quality products and services to global pharmaceutical partners through innovation, research, development, and quality management, accelerating the entire process from pre-clinical to commercial production for our partners.